Orchestra BioMed stockholders elect directors and ratify auditor at 2024 Annual Meeting

Orchestra BioMed Holdings, Inc.

28.6M shares voted (80% of 35.8M eligible); both Class I directors elected.
Eric A. Rose, M.D. received 22.5M for, 2.2M withheld; Jason Aryeh received 24.0M for, 0.6M withheld.
Ratification of Ernst & Young as independent auditor approved with 28.6M for, 25.4K against, 2.4K abstentions.
No other proposals were voted on at the meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.